Zepbound maker Eli Lilly hits $1T market cap - MSN Novo Nordisk had the early lead in the space, but Lilly’s drugs — Mounjaro and Zepbound — have surged in popularity and helped eclipse its rival in prescriptions
Eli Lilly becomes first drugmaker to hit $1 trillion in . . . Over the first nine months of 2025, combined Zepbound and Mounjaro sales reached nearly $19 billion, leapfrogging Merck Co ’s cancer immunotherapy Keytruda and giving Lilly the world’s best-selling drug That progress has put Lilly in position to control a market Wall Street analysts expect to reach $100 billion in annual sales by 2030
日曆月曆